Resistance to BRAF inhibition in BRAF V600E colorectal cancer is associated with PI3K/AKT activation and hypermethylation

被引：0

作者：

Mao, Muling ^{[1
]}

Tsao, Lawrence ^{[1
]}

Dayyani, Farshid ^{[1
]}

Nanda, Vashisht Gopal Yennu ^{[1
]}

Mills, Gordon ^{[1
]}

Bollag, Gideon ^{[2
]}

Davies, Michael ^{[1
]}

Gallick, Gary ^{[1
]}

Kopetz, Scott ^{[1
]}

机构：

[1] MDACC, Houston, TX USA

[2] Plexxikon Inc, Berkeley, CA USA

来源：

CANCER RESEARCH | 2011年 / 71卷

关键词：

D O I：

10.1158/1538-7445.AM2011-LB-228

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB-228

引用

页数：1

共 50 条

[31] Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer
Tak, Eunyoung
An, Hye-In
Lee, Amy Sinyoung
Han, Kyuyoung
Choi, Jiwan
Kim, Hyung-don
Hong, Yong Sang
Kim, Sun Young
Choi, Eun Kyung
Kim, Jeong Eun
Kim, Tae Won
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (05)
[32] BRAF overexpression is associated with BRAF V600E mutation in papillary thyroid carcinomas
da Silva, R. C.
de Paula, H. S. C.
Leal, C. B. Q. S.
Cunha, B. C. R.
de Paula, E. C.
Alencar, R. C. G.
Meneghini, A. J.
Silva, A. M. T. C.
Gontijo, A. P.
Wastowski, I. J.
Saddi, V. A.
GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 5065 - 5075
[33] SUPERIOR OUTCOME FOR BRAF V600E PEDIATRIC GLIOMAS TREATED WITH TARGETED BRAF INHIBITION
Nobre, Liana
Zapotocky, Michal
Ramaswamy, Vijay
Ryall, Scott
Bennett, Julie
Guill, Julia Balaguer
Baroni, Lorena
Bartels, Ute
Bornhorst, Miriam
Boue, Daniel
Chintagumpala, Murali
Cruz, Ofelia
Dahiya, Sonika
Dirks, Peter
Dunkel, Ira
Eisenstat, David
Finch, Elizabeth
Finlay, Jonathan
Frappaz, Didier
Garre, Maria Luisa
Gauvain, Karen
Bechensteen, Anne Grete
Hansford, Jordan
Hauser, Peter
Huang, Annie
Karajannis, Matthias
Kaur, Gurcharanjeet
Larouche, Valerie
Lassaletta, Alvaro
Leary, Sarah
Lin, Frank
McKeown, Tara
Milde, Til
La Madrid, Andres Morales
Morse, Helena
Mushtaq, Naureen
Osorio, Diana
Packer, Roger
Pavelka, Zdenek
Salgado, Duarte
Sabel, Magnus
Solano, Palma
Su, Jack
Sumerauer, David
Toledano, Helen
van Tilburg, Cornelis
Wilson, Bev
Bouffet, Eric
Hawkins, Cynthia
Tabori, Uri
NEURO-ONCOLOGY, 2019, 21 : 184 - 185
[34] BRAF V600E and V600K in Melanoma: Clinicopathologic Correlation
Purgina, B. M.
Jelic, T.
Chiosea, S. I.
MODERN PATHOLOGY, 2012, 25 : 131A - 131A
[35] BRAF V600E and V600K in Melanoma: Clinicopathologic Correlation
Purgina, B. M.
Jelic, T.
Chiosea, S. I.
LABORATORY INVESTIGATION, 2012, 92 : 131A - 131A
[36] Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinoma
Shimizu, Yuki
Maruyama, Kohei
Suzuki, Mai
Kawachi, Hiroshi
Low, Siew-Kee
Oh-hara, Tomoko
Takeuchi, Kengo
Fujita, Naoya
Nagayama, Satoshi
Katayama, Ryohei
CANCER LETTERS, 2022, 543
[37] BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma
Affolter, Kajsa
Samowitz, Wade
Tripp, Sheryl
Bronner, Mary P.
GENES CHROMOSOMES & CANCER, 2013, 52 (08): : 748 - 752
[38] The finding of new subgroups in BRAF V600E mutation positive Colorectal Cancer
Shimizu, Yuki
Gong, Bo
Oh-hara, Tomoko
Nagayama, Satoshi
Fujita, Naoya
Katayama, Ryohei
CANCER SCIENCE, 2018, 109 : 1032 - 1032
[39] Clinical characteristics in colorectal cancer harboring BRAF V600E and non-V600E mutations
Shinozaki, E.
Miki, Y.
Ueno, M.
Igarashi, M.
Chin, K.
Takahari, D.
Ogura, M.
Ichimura, T.
Nakayama, I.
Osumi, H.
Wakatsuki, T.
Matsushima, T.
Yamaguchi, K.
ANNALS OF ONCOLOGY, 2016, 27
[40] BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression
Barras, David
Missiaglia, Edoardo
Wirapati, Pratyaksha
Sieber, Oliver M.
Jorissen, Robert N.
Love, Chris
Molloy, Peter L.
Jones, Ian T.
McLaughlin, Stephen
Gibbs, Peter
Guinney, Justin
Simon, Iris M.
Roth, Arnaud D.
Bosman, Fred T.
Tejpar, Sabine
Delorenzi, Mauro
CLINICAL CANCER RESEARCH, 2017, 23 (01) : 104 - 115

← 1 2 3 4 5 →